Hrain Biotechnology Co., Ltd.   Report issue

For profit Phase 1
Founded: Shanghai China (2015)

Organization Overview

First Clinical Trial
2018
NCT04303520
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Hrain Biotechnology | Hrain Biotechnology Co., Ltd.